FINWIRES · TerminalLIVE
FINWIRES

Update: Mizuho Keeps Price Target on Immix Biopharma to $15, Maintains Outperform Rating

作者

-- (Updated to keep price target unchanged).

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $8.57, Change: $-0.04, Percent Change: -0.41%

相关文章